Berutti Aaron 4
4 · TREACE MEDICAL CONCEPTS, INC. · Filed Mar 10, 2023
Insider Transaction Report
Form 4
Berutti Aaron
SVP, Sales
Transactions
- Award
Common Stock
2023-03-10+29,800→ 42,842 total - Sale
Common Stock
2023-03-09$24.41/sh−733$17,893→ 13,042 total - Award
Stock Option (Right to Buy)
2023-03-10+67,500→ 67,500 totalExercise: $24.07Exp: 2033-03-10→ Stock Option (Right to Buy) (67,500 underlying)
Footnotes (5)
- [F1]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- [F2]Includes 8,962 RSUs.
- [F3]Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date.
- [F4]Includes 38,762 RSUs.
- [F5]The stock option will vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date.